Rome, Italy

Andrea Margonelli


Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 43(Granted Patents)


Location History:

  • Roma RM, IT (1991)
  • Rome, IT (1986 - 1998)

Company Filing History:


Years Active: 1986-1998

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Andrea Margonelli: Innovator in Peptide Compounds

Introduction

Andrea Margonelli is a distinguished inventor based in Rome, Italy. She has made significant contributions to the field of peptide compounds, holding a total of 5 patents. Her work focuses on developing compounds that exhibit various therapeutic activities, including anti-hypertensive and anti-inflammatory effects.

Latest Patents

Among her latest patents are innovative peptide compounds of (L) amino acids and ring molecules. These compounds are characterized by a general formula A--B--C, where A represents a monovalent radical of a L-ring molecule, B is a bivalent radical of a L-alpha-amino acid, and C is a monovalent radical of a L-aromatic molecule. The compounds demonstrate anti-hypertensive, analgesic, immuno-modulating, and anti-inflammatory activities. They are also resistant to enzyme hydrolysis, making them suitable for the preparation of drugs for oral administration. Another notable patent involves compounds with a sequence of three radicals, with the central radical being alpha. These compounds also show similar therapeutic properties and resistance to enzyme hydrolysis.

Career Highlights

Throughout her career, Andrea has worked with notable companies, including Polifarma S.p.a. Her innovative research has positioned her as a key figure in the development of new therapeutic agents.

Collaborations

Andrea has collaborated with esteemed colleagues such as Giovanni Di Stazio and Vincenzo Politi, contributing to the advancement of her research and the development of her patented compounds.

Conclusion

Andrea Margonelli's work in peptide compounds showcases her dedication to innovation in the pharmaceutical field. Her patents reflect her commitment to developing effective therapeutic agents that can significantly impact healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…